Qualuable

About Qualuable

Call Us (423) 794-5750

Championing a patient-centered approach to care, Qualuable Medical Professionals is an Accountable Care Organization (ACO) promoting collaboration among healthcare providers of Northeast Tennessee and Southwest Virginia. Working together and with Medicare, sharing information and responsibility, we're utilizing best practice protocols and pathways to significantly improve not only the health of those we're privileged to serve but the overall health of the communities in which we live.

Deriving our name from the blending of quality, value and ability, Qualuable Medical Professionals is committed to the provision of patient-centered care of improved quality and value.

Qualuable is pleased to be a Medicare ACO.


ACO Name and Location

Qualuable Medical Professionals, LLC
2528 Wesley St. Suite 2
Johnson City, Tennessee 37601

ACO Primary Contact
Primary Contact Name Rich Panek
Primary Contact Phone Number 423-794-2467
Primary Contact Email Address contact@sofha.net

Organizational Information
ACO participants:
ACO governing body:
Member Member's Voting Power Membership Type ACO Participant TIN Legal Business Name/DBA, if Applicable
Last Name First Name Title/Position
Blackmore, M.D. Ron President & Chairman of the Board 1 ACO Participant Representative State of Franklin Healthcare
Hansen, M.D. James Voting Member 1 ACO Participant Representative State of Franklin Healthcare
Hopland, M.D. Kenny Voting Member 1 ACO Participant Representative Medical Care, PLLC
Hopland Steve Voting Member 1 ACO Participant Representative Medical Care, PLLC
Funke, M.D. Robert Voting Member 1 ACO Participant Representative Mountain Region Family Medicine
Misischia, D.O. Kevin Voting Member 1 ACO Participant Representative Mountain Region Family Medicine
Blackwelder, M.D. Reid Voting Member 1 ACO Participant Representative Medical Education Assistance Corporation (ETSU Family Medicine)
Summers, M.D. Jeffery Voting Member 1 ACO Participant Representative Medical Education Assistance Corporation (ETSU Internal Medicine)
Gwaltney, M.D. D. Nelson Voting Member 1 ACO Participant Representative Bristol Surgical Associates
Chandler, M.D. John Voting Member 1 Other Appalachian Orthopedic Associates
Woodard, M.D. Mark Voting Member 1 ACO Participant Representative Northeast Tennessee Emergency Physicians PC
Williams, Jr. Ernest E. Voting Member 1 Medicare Beneficiary Representative  

Key ACO clinical and administrative leadership:
Rich Panek ACO Executive
Dr. David Moulton Medical Director
Dr. Kenny Hopland Compliance Officer
Dr. Kenny Hopland Quality Assurance/Improvement Officer

Associated committees and committee leadership:
Committee Name Committee Leader Name and Position
Contracting & Finance Committee Dr. Kevin Misischia, Chair
Compliance Committee Dr. Kenny Hopland, Chair
Clinical Transformation Committee Dr. David Moulton, Chair
Care Coordination & Quality Committee Dr. David Moulton, Chair

Types of ACO Participants, or combinations of participants, that formed the ACO:
  • Network of individual practices of ACO professionals

Shared Savings and Losses:
Amount of Shared Savings/Losses
  • Second Agreement Period
  • Performance Year 2016, $4,753,066
  • First Agreement Period
  • Performance Year 2015, $5,020,640
  • Performance Year 2014, $7,406,111
  • Performance Year 2013, $6,709,522
Shared Savings Distribution
  • Second Agreement Period
  • Performance Year 2016
  • Proportion invested in infrastructure: 19%
  • Proportion invested in redesigned care processes/resources: 0%
  • Proportion of distribution to ACO participants: 81%
  • First Agreement Period
  • Performance Year 2015
  • Proportion invested in infrastructure: 46%
  • Proportion invested in redesigned care processes/resources: 0%
  • Proportion of distribution to ACO participants: 54%
  • Performance Year 2014
  • Proportion invested in infrastructure: 25%
  • Proportion invested in redesigned care processes/resources: 0%
  • Proportion of distribution to ACO participants: 75%
  • Performance Year 2013
  • Proportion invested in infrastructure: 28%
  • Proportion invested in redesigned care processes/resources: 0%
  • Proportion of distribution to ACO participants: 72%

Quality Performance Results
2016 Quality Performance Results:
ACO# Measure Name Rate ACO Mean
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information 84.61 79.9
ACO-2 CAHPS: How Well Your Providers Communicate 92.85 92.63
ACO-3 CAHPS: Patients' Rating of Provider 92.85 91.93
ACO-4 CAHPS: Access to Specialists 85.03 83.52
ACO-5 CAHPS: Health Promotion and Education 61.8 60
ACO-6 CAHPS: Shared Decision Making 77.76 75.28
ACO-7 CAHPS: Health Status/Functional Status 72.21 71.82
ACO-34 CAHPS: Stewardship of Patient Resources 28.74 27.52
ACO-8 Risk Standardized, All Condition Readmissions 15.06 14.7
ACO-35 Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM) 17.34 18.17
ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes 54.58 53.2
ACO-37 All-Cause Unplanned Admissions for Patients with Heart Failure 72.91 75.23
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 59.84 59.81
ACO-9 Ambulatory Sensitive Conditions Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5) 9.42 9.27
ACO-10 Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8 ) 13.15 14.53
ACO-11 Percent of PCPs who Successfully Meet Meaningful Use Requirements 91.79 82.72
ACO-39 Documentation of Current Medications in the Medical Record 92.16 87.54
ACO-13 Falls: Screening for Future Fall Risk 96.72 64.04
ACO-14 Preventive Care and Screening: Influenza Immunization 94.53 68.32
ACO-15 Pneumonia Vaccination Status for Older Adults 90.39 69.21
ACO-16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow Up 97.04 74.45
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 98.37 90.98
ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 86.96 53.63
ACO-19 Colorectal Cancer Screening 81.57 61.52
ACO-20 Breast Cancer Screening 85.69 67.61
ACO-21 Preventive Care and Screening: Screening for High Blood Pressure and Follow-up Documented 95.33 76.84
ACO-42 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 85.21 77.72
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control 9.06 18.24
ACO-41 Diabetes: Eye Exam 66.44 44.94
ACO-28 Hypertension (HTN): Controlling High Blood Pressure 77.56 70.52
ACO-30 Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic 93.29 85.05
ACO-31 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) 87.74 88.67
ACO-33 Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%) 93.62 79.67

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.



Note: In the Quality Performance Results file(s) above, search for “Qualuable Medical Professionals, LLC” to view the quality performance results. This ACO can also be found by using the ACO ID A22066 in the public use files on data.cms.gov.

Payment Rule Waivers
  • No, our ACO does not use the SNF 3-Day Rule Waiver.


Last updated on December 1, 2017